Earnings preview: Market has low expectations ahead of Advaxis' Q3 report
Earnings preview: Market has low expectations ahead of Advaxis’ Q3 report
Advaxis (NASDAQ: ADXS), a late-stage biotech firm, is one of the worst-performing healthcare stocks that continuously disappointed investors over the years. Though the company returned to profitability briefly at the beginning of the year, after a long losing streak, it could not sustain the momentum.
Advaxis‘ third-quarter results are tentatively scheduled for release on September 9 at 4:05…
View On WordPress









